nodes	percent_of_prediction	percent_of_DWPC	metapath
Mifepristone—PGR—multiple sclerosis	0.388	1	CbGaD
Mifepristone—PGR—Betamethasone—multiple sclerosis	0.0649	0.129	CbGbCtD
Mifepristone—NR3C1—Methylprednisolone—multiple sclerosis	0.051	0.102	CbGbCtD
Mifepristone—NR3C1—Triamcinolone—multiple sclerosis	0.0386	0.077	CbGbCtD
Mifepristone—PGR—Dexamethasone—multiple sclerosis	0.0377	0.0752	CbGbCtD
Mifepristone—ABCC1—Mitoxantrone—multiple sclerosis	0.0359	0.0715	CbGbCtD
Mifepristone—NR3C1—Betamethasone—multiple sclerosis	0.0331	0.066	CbGbCtD
Mifepristone—NR3C1—Prednisolone—multiple sclerosis	0.0327	0.0652	CbGbCtD
Mifepristone—NR3C1—Prednisone—multiple sclerosis	0.0309	0.0615	CbGbCtD
Mifepristone—NR3C1—Dexamethasone—multiple sclerosis	0.0193	0.0384	CbGbCtD
Mifepristone—CYP2D6—Fingolimod—multiple sclerosis	0.0174	0.0346	CbGbCtD
Mifepristone—ABCC1—Methotrexate—multiple sclerosis	0.015	0.0298	CbGbCtD
Mifepristone—ABCB1—Methylprednisolone—multiple sclerosis	0.0119	0.0236	CbGbCtD
Mifepristone—CYP3A4—Fingolimod—multiple sclerosis	0.011	0.022	CbGbCtD
Mifepristone—CYP3A7—Dexamethasone—multiple sclerosis	0.00919	0.0183	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.00919	0.0183	CbGbCtD
Mifepristone—ABCB1—Mitoxantrone—multiple sclerosis	0.00866	0.0173	CbGbCtD
Mifepristone—ABCB1—Betamethasone—multiple sclerosis	0.00772	0.0154	CbGbCtD
Mifepristone—ABCB1—Prednisolone—multiple sclerosis	0.00761	0.0152	CbGbCtD
Mifepristone—ABCB1—Prednisone—multiple sclerosis	0.00719	0.0143	CbGbCtD
Mifepristone—CYP3A4—Methylprednisolone—multiple sclerosis	0.00711	0.0142	CbGbCtD
Mifepristone—CYP3A5—Dexamethasone—multiple sclerosis	0.0069	0.0137	CbGbCtD
Mifepristone—CYP3A4—Triamcinolone—multiple sclerosis	0.00539	0.0107	CbGbCtD
Mifepristone—CYP3A4—Mitoxantrone—multiple sclerosis	0.00519	0.0103	CbGbCtD
Mifepristone—CYP3A4—Betamethasone—multiple sclerosis	0.00462	0.00921	CbGbCtD
Mifepristone—CYP3A4—Prednisolone—multiple sclerosis	0.00456	0.00909	CbGbCtD
Mifepristone—ABCB1—Dexamethasone—multiple sclerosis	0.00449	0.00894	CbGbCtD
Mifepristone—CYP3A4—Prednisone—multiple sclerosis	0.00431	0.00858	CbGbCtD
Mifepristone—CYP2D6—Dexamethasone—multiple sclerosis	0.00423	0.00843	CbGbCtD
Mifepristone—ABCB1—Methotrexate—multiple sclerosis	0.00361	0.00719	CbGbCtD
Mifepristone—CYP3A4—Dexamethasone—multiple sclerosis	0.00269	0.00536	CbGbCtD
Mifepristone—Hypersensitivity—Azathioprine—multiple sclerosis	0.000149	0.00181	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000149	0.00181	CcSEcCtD
Mifepristone—Malaise—Prednisolone—multiple sclerosis	0.000148	0.0018	CcSEcCtD
Mifepristone—Nausea—Cladribine—multiple sclerosis	0.000148	0.00179	CcSEcCtD
Mifepristone—Back pain—Triamcinolone—multiple sclerosis	0.000146	0.00178	CcSEcCtD
Mifepristone—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000146	0.00177	CcSEcCtD
Mifepristone—Somnolence—Mitoxantrone—multiple sclerosis	0.000145	0.00177	CcSEcCtD
Mifepristone—Angiopathy—Dexamethasone—multiple sclerosis	0.000143	0.00174	CcSEcCtD
Mifepristone—Angiopathy—Betamethasone—multiple sclerosis	0.000143	0.00174	CcSEcCtD
Mifepristone—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000142	0.00173	CcSEcCtD
Mifepristone—Hypertension—Prednisolone—multiple sclerosis	0.000142	0.00172	CcSEcCtD
Mifepristone—Fatigue—Mitoxantrone—multiple sclerosis	0.000141	0.00171	CcSEcCtD
Mifepristone—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.00014	0.0017	CcSEcCtD
Mifepristone—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.00014	0.0017	CcSEcCtD
Mifepristone—Pain—Mitoxantrone—multiple sclerosis	0.00014	0.0017	CcSEcCtD
Mifepristone—Constipation—Mitoxantrone—multiple sclerosis	0.00014	0.0017	CcSEcCtD
Mifepristone—Diarrhoea—Azathioprine—multiple sclerosis	0.000138	0.00168	CcSEcCtD
Mifepristone—Discomfort—Prednisolone—multiple sclerosis	0.000138	0.00168	CcSEcCtD
Mifepristone—Angioedema—Triamcinolone—multiple sclerosis	0.000138	0.00168	CcSEcCtD
Mifepristone—Haemoglobin—Prednisone—multiple sclerosis	0.000138	0.00167	CcSEcCtD
Mifepristone—Angioedema—Methylprednisolone—multiple sclerosis	0.000138	0.00167	CcSEcCtD
Mifepristone—Haemorrhage—Prednisone—multiple sclerosis	0.000137	0.00167	CcSEcCtD
Mifepristone—Malaise—Triamcinolone—multiple sclerosis	0.000136	0.00166	CcSEcCtD
Mifepristone—Malaise—Methylprednisolone—multiple sclerosis	0.000136	0.00165	CcSEcCtD
Mifepristone—Connective tissue disorder—Prednisone—multiple sclerosis	0.000135	0.00164	CcSEcCtD
Mifepristone—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000135	0.00164	CcSEcCtD
Mifepristone—Oedema—Prednisolone—multiple sclerosis	0.000134	0.00163	CcSEcCtD
Mifepristone—Dizziness—Azathioprine—multiple sclerosis	0.000134	0.00162	CcSEcCtD
Mifepristone—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000134	0.00162	CcSEcCtD
Mifepristone—Hypertension—Triamcinolone—multiple sclerosis	0.00013	0.00159	CcSEcCtD
Mifepristone—Hypertension—Methylprednisolone—multiple sclerosis	0.00013	0.00158	CcSEcCtD
Mifepristone—Urticaria—Mitoxantrone—multiple sclerosis	0.00013	0.00158	CcSEcCtD
Mifepristone—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000129	0.00157	CcSEcCtD
Mifepristone—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000129	0.00157	CcSEcCtD
Mifepristone—Myalgia—Triamcinolone—multiple sclerosis	0.000129	0.00156	CcSEcCtD
Mifepristone—Vomiting—Azathioprine—multiple sclerosis	0.000129	0.00156	CcSEcCtD
Mifepristone—Arthralgia—Methylprednisolone—multiple sclerosis	0.000128	0.00156	CcSEcCtD
Mifepristone—Myalgia—Methylprednisolone—multiple sclerosis	0.000128	0.00156	CcSEcCtD
Mifepristone—Anxiety—Methylprednisolone—multiple sclerosis	0.000128	0.00155	CcSEcCtD
Mifepristone—Infestation NOS—Methotrexate—multiple sclerosis	0.000128	0.00155	CcSEcCtD
Mifepristone—Infestation—Methotrexate—multiple sclerosis	0.000128	0.00155	CcSEcCtD
Mifepristone—Rash—Azathioprine—multiple sclerosis	0.000128	0.00155	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000127	0.00155	CcSEcCtD
Mifepristone—Dermatitis—Azathioprine—multiple sclerosis	0.000127	0.00155	CcSEcCtD
Mifepristone—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000127	0.00155	CcSEcCtD
Mifepristone—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000127	0.00155	CcSEcCtD
Mifepristone—Discomfort—Triamcinolone—multiple sclerosis	0.000127	0.00154	CcSEcCtD
Mifepristone—Discomfort—Methylprednisolone—multiple sclerosis	0.000127	0.00154	CcSEcCtD
Mifepristone—Headache—Azathioprine—multiple sclerosis	0.000127	0.00154	CcSEcCtD
Mifepristone—Dry mouth—Triamcinolone—multiple sclerosis	0.000126	0.00153	CcSEcCtD
Mifepristone—Angioedema—Dexamethasone—multiple sclerosis	0.000125	0.00152	CcSEcCtD
Mifepristone—Angioedema—Betamethasone—multiple sclerosis	0.000125	0.00152	CcSEcCtD
Mifepristone—Angiopathy—Prednisone—multiple sclerosis	0.000124	0.00151	CcSEcCtD
Mifepristone—Malaise—Betamethasone—multiple sclerosis	0.000124	0.0015	CcSEcCtD
Mifepristone—Malaise—Dexamethasone—multiple sclerosis	0.000124	0.0015	CcSEcCtD
Mifepristone—Oedema—Triamcinolone—multiple sclerosis	0.000123	0.0015	CcSEcCtD
Mifepristone—Infection—Triamcinolone—multiple sclerosis	0.000123	0.00149	CcSEcCtD
Mifepristone—Infection—Methylprednisolone—multiple sclerosis	0.000122	0.00149	CcSEcCtD
Mifepristone—Insomnia—Prednisolone—multiple sclerosis	0.000121	0.00147	CcSEcCtD
Mifepristone—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000121	0.00147	CcSEcCtD
Mifepristone—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00012	0.00146	CcSEcCtD
Mifepristone—Mental disorder—Prednisone—multiple sclerosis	0.00012	0.00146	CcSEcCtD
Mifepristone—Nausea—Azathioprine—multiple sclerosis	0.00012	0.00146	CcSEcCtD
Mifepristone—Skin disorder—Methylprednisolone—multiple sclerosis	0.00012	0.00145	CcSEcCtD
Mifepristone—Malnutrition—Prednisone—multiple sclerosis	0.000119	0.00145	CcSEcCtD
Mifepristone—Hypertension—Dexamethasone—multiple sclerosis	0.000118	0.00144	CcSEcCtD
Mifepristone—Hypertension—Betamethasone—multiple sclerosis	0.000118	0.00144	CcSEcCtD
Mifepristone—Asthenia—Mitoxantrone—multiple sclerosis	0.000117	0.00142	CcSEcCtD
Mifepristone—Myalgia—Dexamethasone—multiple sclerosis	0.000117	0.00142	CcSEcCtD
Mifepristone—Myalgia—Betamethasone—multiple sclerosis	0.000117	0.00142	CcSEcCtD
Mifepristone—Anxiety—Betamethasone—multiple sclerosis	0.000116	0.00141	CcSEcCtD
Mifepristone—Anxiety—Dexamethasone—multiple sclerosis	0.000116	0.00141	CcSEcCtD
Mifepristone—Discomfort—Dexamethasone—multiple sclerosis	0.000115	0.0014	CcSEcCtD
Mifepristone—Discomfort—Betamethasone—multiple sclerosis	0.000115	0.0014	CcSEcCtD
Mifepristone—Haemoglobin—Methotrexate—multiple sclerosis	0.000115	0.0014	CcSEcCtD
Mifepristone—Hypotension—Methylprednisolone—multiple sclerosis	0.000115	0.0014	CcSEcCtD
Mifepristone—Pain—Prednisolone—multiple sclerosis	0.000115	0.00139	CcSEcCtD
Mifepristone—Haemorrhage—Methotrexate—multiple sclerosis	0.000115	0.00139	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000112	0.00137	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000112	0.00136	CcSEcCtD
Mifepristone—Oedema—Dexamethasone—multiple sclerosis	0.000112	0.00136	CcSEcCtD
Mifepristone—Oedema—Betamethasone—multiple sclerosis	0.000112	0.00136	CcSEcCtD
Mifepristone—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000112	0.00136	CcSEcCtD
Mifepristone—Insomnia—Triamcinolone—multiple sclerosis	0.000112	0.00136	CcSEcCtD
Mifepristone—Insomnia—Methylprednisolone—multiple sclerosis	0.000111	0.00135	CcSEcCtD
Mifepristone—Infection—Dexamethasone—multiple sclerosis	0.000111	0.00135	CcSEcCtD
Mifepristone—Infection—Betamethasone—multiple sclerosis	0.000111	0.00135	CcSEcCtD
Mifepristone—Ill-defined disorder—Prednisone—multiple sclerosis	0.000111	0.00135	CcSEcCtD
Mifepristone—Feeling abnormal—Prednisolone—multiple sclerosis	0.000111	0.00134	CcSEcCtD
Mifepristone—Dyspnoea—Triamcinolone—multiple sclerosis	0.00011	0.00134	CcSEcCtD
Mifepristone—Nervous system disorder—Betamethasone—multiple sclerosis	0.00011	0.00133	CcSEcCtD
Mifepristone—Nervous system disorder—Dexamethasone—multiple sclerosis	0.00011	0.00133	CcSEcCtD
Mifepristone—Angioedema—Prednisone—multiple sclerosis	0.000109	0.00133	CcSEcCtD
Mifepristone—Malaise—Prednisone—multiple sclerosis	0.000108	0.00131	CcSEcCtD
Mifepristone—Anorexia—Dexamethasone—multiple sclerosis	0.000107	0.0013	CcSEcCtD
Mifepristone—Anorexia—Betamethasone—multiple sclerosis	0.000107	0.0013	CcSEcCtD
Mifepristone—Urticaria—Prednisolone—multiple sclerosis	0.000107	0.00129	CcSEcCtD
Mifepristone—Fatigue—Triamcinolone—multiple sclerosis	0.000106	0.00129	CcSEcCtD
Mifepristone—Fatigue—Methylprednisolone—multiple sclerosis	0.000106	0.00129	CcSEcCtD
Mifepristone—Pain—Triamcinolone—multiple sclerosis	0.000105	0.00128	CcSEcCtD
Mifepristone—Hypotension—Betamethasone—multiple sclerosis	0.000105	0.00127	CcSEcCtD
Mifepristone—Hypotension—Dexamethasone—multiple sclerosis	0.000105	0.00127	CcSEcCtD
Mifepristone—Angiopathy—Methotrexate—multiple sclerosis	0.000104	0.00126	CcSEcCtD
Mifepristone—Vomiting—Mitoxantrone—multiple sclerosis	0.000104	0.00126	CcSEcCtD
Mifepristone—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000103	0.00126	CcSEcCtD
Mifepristone—Hypertension—Prednisone—multiple sclerosis	0.000103	0.00125	CcSEcCtD
Mifepristone—Rash—Mitoxantrone—multiple sclerosis	0.000103	0.00125	CcSEcCtD
Mifepristone—Dermatitis—Mitoxantrone—multiple sclerosis	0.000103	0.00125	CcSEcCtD
Mifepristone—Chills—Methotrexate—multiple sclerosis	0.000103	0.00125	CcSEcCtD
Mifepristone—Headache—Mitoxantrone—multiple sclerosis	0.000102	0.00124	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000102	0.00124	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000102	0.00124	CcSEcCtD
Mifepristone—Myalgia—Prednisone—multiple sclerosis	0.000102	0.00124	CcSEcCtD
Mifepristone—Arthralgia—Prednisone—multiple sclerosis	0.000102	0.00124	CcSEcCtD
Mifepristone—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000102	0.00123	CcSEcCtD
Mifepristone—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000101	0.00123	CcSEcCtD
Mifepristone—Anxiety—Prednisone—multiple sclerosis	0.000101	0.00123	CcSEcCtD
Mifepristone—Insomnia—Dexamethasone—multiple sclerosis	0.000101	0.00123	CcSEcCtD
Mifepristone—Insomnia—Betamethasone—multiple sclerosis	0.000101	0.00123	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000101	0.00123	CcSEcCtD
Mifepristone—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000101	0.00122	CcSEcCtD
Mifepristone—Discomfort—Prednisone—multiple sclerosis	0.0001	0.00122	CcSEcCtD
Mifepristone—Mental disorder—Methotrexate—multiple sclerosis	0.0001	0.00122	CcSEcCtD
Mifepristone—Malnutrition—Methotrexate—multiple sclerosis	9.98e-05	0.00121	CcSEcCtD
Mifepristone—Hypersensitivity—Prednisolone—multiple sclerosis	9.88e-05	0.0012	CcSEcCtD
Mifepristone—Urticaria—Triamcinolone—multiple sclerosis	9.8e-05	0.00119	CcSEcCtD
Mifepristone—Urticaria—Methylprednisolone—multiple sclerosis	9.78e-05	0.00119	CcSEcCtD
Mifepristone—Body temperature increased—Triamcinolone—multiple sclerosis	9.75e-05	0.00118	CcSEcCtD
Mifepristone—Oedema—Prednisone—multiple sclerosis	9.75e-05	0.00118	CcSEcCtD
Mifepristone—Abdominal pain—Methylprednisolone—multiple sclerosis	9.73e-05	0.00118	CcSEcCtD
Mifepristone—Decreased appetite—Betamethasone—multiple sclerosis	9.73e-05	0.00118	CcSEcCtD
Mifepristone—Decreased appetite—Dexamethasone—multiple sclerosis	9.73e-05	0.00118	CcSEcCtD
Mifepristone—Nausea—Mitoxantrone—multiple sclerosis	9.71e-05	0.00118	CcSEcCtD
Mifepristone—Infection—Prednisone—multiple sclerosis	9.68e-05	0.00118	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Betamethasone—multiple sclerosis	9.66e-05	0.00117	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	9.66e-05	0.00117	CcSEcCtD
Mifepristone—Back pain—Methotrexate—multiple sclerosis	9.65e-05	0.00117	CcSEcCtD
Mifepristone—Fatigue—Dexamethasone—multiple sclerosis	9.65e-05	0.00117	CcSEcCtD
Mifepristone—Fatigue—Betamethasone—multiple sclerosis	9.65e-05	0.00117	CcSEcCtD
Mifepristone—Pain—Dexamethasone—multiple sclerosis	9.57e-05	0.00116	CcSEcCtD
Mifepristone—Pain—Betamethasone—multiple sclerosis	9.57e-05	0.00116	CcSEcCtD
Mifepristone—Nervous system disorder—Prednisone—multiple sclerosis	9.56e-05	0.00116	CcSEcCtD
Mifepristone—Skin disorder—Prednisone—multiple sclerosis	9.47e-05	0.00115	CcSEcCtD
Mifepristone—Anorexia—Prednisone—multiple sclerosis	9.29e-05	0.00113	CcSEcCtD
Mifepristone—Ill-defined disorder—Methotrexate—multiple sclerosis	9.26e-05	0.00112	CcSEcCtD
Mifepristone—Feeling abnormal—Betamethasone—multiple sclerosis	9.22e-05	0.00112	CcSEcCtD
Mifepristone—Feeling abnormal—Dexamethasone—multiple sclerosis	9.22e-05	0.00112	CcSEcCtD
Mifepristone—Gastrointestinal pain—Dexamethasone—multiple sclerosis	9.15e-05	0.00111	CcSEcCtD
Mifepristone—Gastrointestinal pain—Betamethasone—multiple sclerosis	9.15e-05	0.00111	CcSEcCtD
Mifepristone—Hypersensitivity—Triamcinolone—multiple sclerosis	9.09e-05	0.0011	CcSEcCtD
Mifepristone—Hypersensitivity—Methylprednisolone—multiple sclerosis	9.07e-05	0.0011	CcSEcCtD
Mifepristone—Malaise—Methotrexate—multiple sclerosis	9e-05	0.00109	CcSEcCtD
Mifepristone—Urticaria—Betamethasone—multiple sclerosis	8.89e-05	0.00108	CcSEcCtD
Mifepristone—Urticaria—Dexamethasone—multiple sclerosis	8.89e-05	0.00108	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Prednisone—multiple sclerosis	8.88e-05	0.00108	CcSEcCtD
Mifepristone—Dizziness—Prednisolone—multiple sclerosis	8.87e-05	0.00108	CcSEcCtD
Mifepristone—Asthenia—Triamcinolone—multiple sclerosis	8.85e-05	0.00108	CcSEcCtD
Mifepristone—Abdominal pain—Betamethasone—multiple sclerosis	8.85e-05	0.00107	CcSEcCtD
Mifepristone—Body temperature increased—Betamethasone—multiple sclerosis	8.85e-05	0.00107	CcSEcCtD
Mifepristone—Abdominal pain—Dexamethasone—multiple sclerosis	8.85e-05	0.00107	CcSEcCtD
Mifepristone—Body temperature increased—Dexamethasone—multiple sclerosis	8.85e-05	0.00107	CcSEcCtD
Mifepristone—Asthenia—Methylprednisolone—multiple sclerosis	8.83e-05	0.00107	CcSEcCtD
Mifepristone—Insomnia—Prednisone—multiple sclerosis	8.81e-05	0.00107	CcSEcCtD
Mifepristone—Pruritus—Triamcinolone—multiple sclerosis	8.73e-05	0.00106	CcSEcCtD
Mifepristone—Pruritus—Methylprednisolone—multiple sclerosis	8.71e-05	0.00106	CcSEcCtD
Mifepristone—Myalgia—Methotrexate—multiple sclerosis	8.5e-05	0.00103	CcSEcCtD
Mifepristone—Arthralgia—Methotrexate—multiple sclerosis	8.5e-05	0.00103	CcSEcCtD
Mifepristone—Decreased appetite—Prednisone—multiple sclerosis	8.47e-05	0.00103	CcSEcCtD
Mifepristone—Rash—Prednisolone—multiple sclerosis	8.46e-05	0.00103	CcSEcCtD
Mifepristone—Dermatitis—Prednisolone—multiple sclerosis	8.45e-05	0.00103	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	8.44e-05	0.00103	CcSEcCtD
Mifepristone—Diarrhoea—Methylprednisolone—multiple sclerosis	8.42e-05	0.00102	CcSEcCtD
Mifepristone—Fatigue—Prednisone—multiple sclerosis	8.4e-05	0.00102	CcSEcCtD
Mifepristone—Headache—Prednisolone—multiple sclerosis	8.4e-05	0.00102	CcSEcCtD
Mifepristone—Discomfort—Methotrexate—multiple sclerosis	8.39e-05	0.00102	CcSEcCtD
Mifepristone—Constipation—Prednisone—multiple sclerosis	8.33e-05	0.00101	CcSEcCtD
Mifepristone—Dizziness—Triamcinolone—multiple sclerosis	8.16e-05	0.000991	CcSEcCtD
Mifepristone—Dizziness—Methylprednisolone—multiple sclerosis	8.14e-05	0.000989	CcSEcCtD
Mifepristone—Infection—Methotrexate—multiple sclerosis	8.09e-05	0.000983	CcSEcCtD
Mifepristone—Feeling abnormal—Prednisone—multiple sclerosis	8.03e-05	0.000976	CcSEcCtD
Mifepristone—Asthenia—Dexamethasone—multiple sclerosis	8.03e-05	0.000975	CcSEcCtD
Mifepristone—Asthenia—Betamethasone—multiple sclerosis	8.03e-05	0.000975	CcSEcCtD
Mifepristone—Nervous system disorder—Methotrexate—multiple sclerosis	7.99e-05	0.00097	CcSEcCtD
Mifepristone—Gastrointestinal pain—Prednisone—multiple sclerosis	7.97e-05	0.000968	CcSEcCtD
Mifepristone—Nausea—Prednisolone—multiple sclerosis	7.97e-05	0.000968	CcSEcCtD
Mifepristone—Pruritus—Betamethasone—multiple sclerosis	7.92e-05	0.000962	CcSEcCtD
Mifepristone—Pruritus—Dexamethasone—multiple sclerosis	7.92e-05	0.000962	CcSEcCtD
Mifepristone—Skin disorder—Methotrexate—multiple sclerosis	7.91e-05	0.000961	CcSEcCtD
Mifepristone—Vomiting—Triamcinolone—multiple sclerosis	7.84e-05	0.000953	CcSEcCtD
Mifepristone—Vomiting—Methylprednisolone—multiple sclerosis	7.82e-05	0.000951	CcSEcCtD
Mifepristone—Rash—Triamcinolone—multiple sclerosis	7.78e-05	0.000945	CcSEcCtD
Mifepristone—Dermatitis—Triamcinolone—multiple sclerosis	7.77e-05	0.000944	CcSEcCtD
Mifepristone—Anorexia—Methotrexate—multiple sclerosis	7.76e-05	0.000943	CcSEcCtD
Mifepristone—Rash—Methylprednisolone—multiple sclerosis	7.76e-05	0.000943	CcSEcCtD
Mifepristone—Dermatitis—Methylprednisolone—multiple sclerosis	7.75e-05	0.000942	CcSEcCtD
Mifepristone—Urticaria—Prednisone—multiple sclerosis	7.74e-05	0.000941	CcSEcCtD
Mifepristone—Headache—Triamcinolone—multiple sclerosis	7.73e-05	0.000939	CcSEcCtD
Mifepristone—Headache—Methylprednisolone—multiple sclerosis	7.71e-05	0.000937	CcSEcCtD
Mifepristone—Abdominal pain—Prednisone—multiple sclerosis	7.7e-05	0.000936	CcSEcCtD
Mifepristone—Body temperature increased—Prednisone—multiple sclerosis	7.7e-05	0.000936	CcSEcCtD
Mifepristone—Diarrhoea—Betamethasone—multiple sclerosis	7.66e-05	0.00093	CcSEcCtD
Mifepristone—Diarrhoea—Dexamethasone—multiple sclerosis	7.66e-05	0.00093	CcSEcCtD
Mifepristone—Hypotension—Methotrexate—multiple sclerosis	7.61e-05	0.000925	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	7.42e-05	0.000901	CcSEcCtD
Mifepristone—Dizziness—Betamethasone—multiple sclerosis	7.4e-05	0.000899	CcSEcCtD
Mifepristone—Dizziness—Dexamethasone—multiple sclerosis	7.4e-05	0.000899	CcSEcCtD
Mifepristone—Insomnia—Methotrexate—multiple sclerosis	7.37e-05	0.000895	CcSEcCtD
Mifepristone—Nausea—Triamcinolone—multiple sclerosis	7.33e-05	0.00089	CcSEcCtD
Mifepristone—Nausea—Methylprednisolone—multiple sclerosis	7.31e-05	0.000888	CcSEcCtD
Mifepristone—Dyspnoea—Methotrexate—multiple sclerosis	7.26e-05	0.000882	CcSEcCtD
Mifepristone—Somnolence—Methotrexate—multiple sclerosis	7.24e-05	0.00088	CcSEcCtD
Mifepristone—Hypersensitivity—Prednisone—multiple sclerosis	7.18e-05	0.000872	CcSEcCtD
Mifepristone—CYP2D6—Metapathway biotransformation—CYP27B1—multiple sclerosis	7.14e-05	0.0026	CbGpPWpGaD
Mifepristone—CYP2D6—Metapathway biotransformation—CYP24A1—multiple sclerosis	7.14e-05	0.0026	CbGpPWpGaD
Mifepristone—Vomiting—Betamethasone—multiple sclerosis	7.12e-05	0.000864	CcSEcCtD
Mifepristone—Vomiting—Dexamethasone—multiple sclerosis	7.12e-05	0.000864	CcSEcCtD
Mifepristone—PGR—Validated nuclear estrogen receptor alpha network—MYC—multiple sclerosis	7.1e-05	0.00258	CbGpPWpGaD
Mifepristone—Decreased appetite—Methotrexate—multiple sclerosis	7.08e-05	0.00086	CcSEcCtD
Mifepristone—Rash—Betamethasone—multiple sclerosis	7.06e-05	0.000857	CcSEcCtD
Mifepristone—Rash—Dexamethasone—multiple sclerosis	7.06e-05	0.000857	CcSEcCtD
Mifepristone—Dermatitis—Dexamethasone—multiple sclerosis	7.05e-05	0.000856	CcSEcCtD
Mifepristone—Dermatitis—Betamethasone—multiple sclerosis	7.05e-05	0.000856	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Methotrexate—multiple sclerosis	7.03e-05	0.000854	CcSEcCtD
Mifepristone—Fatigue—Methotrexate—multiple sclerosis	7.02e-05	0.000853	CcSEcCtD
Mifepristone—Headache—Dexamethasone—multiple sclerosis	7.01e-05	0.000852	CcSEcCtD
Mifepristone—Headache—Betamethasone—multiple sclerosis	7.01e-05	0.000852	CcSEcCtD
Mifepristone—Asthenia—Prednisone—multiple sclerosis	6.99e-05	0.000849	CcSEcCtD
Mifepristone—Pain—Methotrexate—multiple sclerosis	6.97e-05	0.000846	CcSEcCtD
Mifepristone—Pruritus—Prednisone—multiple sclerosis	6.9e-05	0.000838	CcSEcCtD
Mifepristone—AR—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	6.8e-05	0.00247	CbGpPWpGaD
Mifepristone—Feeling abnormal—Methotrexate—multiple sclerosis	6.71e-05	0.000815	CcSEcCtD
Mifepristone—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	6.71e-05	0.00244	CbGpPWpGaD
Mifepristone—Diarrhoea—Prednisone—multiple sclerosis	6.67e-05	0.00081	CcSEcCtD
Mifepristone—Gastrointestinal pain—Methotrexate—multiple sclerosis	6.66e-05	0.000809	CcSEcCtD
Mifepristone—Nausea—Betamethasone—multiple sclerosis	6.65e-05	0.000808	CcSEcCtD
Mifepristone—Nausea—Dexamethasone—multiple sclerosis	6.65e-05	0.000808	CcSEcCtD
Mifepristone—ABCB1—Allograft Rejection—CD28—multiple sclerosis	6.52e-05	0.00237	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—IL10—multiple sclerosis	6.49e-05	0.00236	CbGpPWpGaD
Mifepristone—Urticaria—Methotrexate—multiple sclerosis	6.47e-05	0.000786	CcSEcCtD
Mifepristone—PGR—Signaling by ERBB4—CD80—multiple sclerosis	6.47e-05	0.00235	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—CCL2—multiple sclerosis	6.46e-05	0.00235	CbGpPWpGaD
Mifepristone—Dizziness—Prednisone—multiple sclerosis	6.44e-05	0.000783	CcSEcCtD
Mifepristone—Body temperature increased—Methotrexate—multiple sclerosis	6.44e-05	0.000782	CcSEcCtD
Mifepristone—Abdominal pain—Methotrexate—multiple sclerosis	6.44e-05	0.000782	CcSEcCtD
Mifepristone—AR—Gene Expression—ZNF746—multiple sclerosis	6.44e-05	0.00234	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—multiple sclerosis	6.37e-05	0.00231	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	6.35e-05	0.00231	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	6.23e-05	0.00227	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	6.2e-05	0.00226	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	6.2e-05	0.00226	CbGpPWpGaD
Mifepristone—Vomiting—Prednisone—multiple sclerosis	6.2e-05	0.000753	CcSEcCtD
Mifepristone—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	6.18e-05	0.00225	CbGpPWpGaD
Mifepristone—Rash—Prednisone—multiple sclerosis	6.15e-05	0.000747	CcSEcCtD
Mifepristone—Dermatitis—Prednisone—multiple sclerosis	6.14e-05	0.000746	CcSEcCtD
Mifepristone—Headache—Prednisone—multiple sclerosis	6.11e-05	0.000742	CcSEcCtD
Mifepristone—Hypersensitivity—Methotrexate—multiple sclerosis	6e-05	0.000729	CcSEcCtD
Mifepristone—CYP3A7—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.97e-05	0.00217	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—CD40—multiple sclerosis	5.95e-05	0.00216	CbGpPWpGaD
Mifepristone—AR—Gene Expression—PTBP1—multiple sclerosis	5.89e-05	0.00214	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	5.86e-05	0.00213	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—U2AF2—multiple sclerosis	5.86e-05	0.00213	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—HNRNPA1—multiple sclerosis	5.86e-05	0.00213	CbGpPWpGaD
Mifepristone—Asthenia—Methotrexate—multiple sclerosis	5.84e-05	0.00071	CcSEcCtD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—POMC—multiple sclerosis	5.82e-05	0.00212	CbGpPWpGaD
Mifepristone—Nausea—Prednisone—multiple sclerosis	5.79e-05	0.000703	CcSEcCtD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	5.78e-05	0.0021	CbGpPWpGaD
Mifepristone—Pruritus—Methotrexate—multiple sclerosis	5.76e-05	0.0007	CcSEcCtD
Mifepristone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	5.67e-05	0.00206	CbGpPWpGaD
Mifepristone—Diarrhoea—Methotrexate—multiple sclerosis	5.57e-05	0.000677	CcSEcCtD
Mifepristone—NR3C1—AP-1 transcription factor network—IFNG—multiple sclerosis	5.5e-05	0.002	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—multiple sclerosis	5.48e-05	0.00199	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—TYK2—multiple sclerosis	5.46e-05	0.00199	CbGpPWpGaD
Mifepristone—Dizziness—Methotrexate—multiple sclerosis	5.39e-05	0.000654	CcSEcCtD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	5.36e-05	0.00195	CbGpPWpGaD
Mifepristone—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.32e-05	0.00194	CbGpPWpGaD
Mifepristone—Vomiting—Methotrexate—multiple sclerosis	5.18e-05	0.000629	CcSEcCtD
Mifepristone—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	5.16e-05	0.00188	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	5.16e-05	0.00188	CbGpPWpGaD
Mifepristone—Rash—Methotrexate—multiple sclerosis	5.14e-05	0.000624	CcSEcCtD
Mifepristone—Dermatitis—Methotrexate—multiple sclerosis	5.13e-05	0.000623	CcSEcCtD
Mifepristone—NR3C1—Adipogenesis—FAS—multiple sclerosis	5.11e-05	0.00186	CbGpPWpGaD
Mifepristone—Headache—Methotrexate—multiple sclerosis	5.1e-05	0.00062	CcSEcCtD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	4.95e-05	0.0018	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—IL10—multiple sclerosis	4.92e-05	0.00179	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—IL2—multiple sclerosis	4.88e-05	0.00178	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—ZNF746—multiple sclerosis	4.88e-05	0.00178	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—multiple sclerosis	4.84e-05	0.00176	CbGpPWpGaD
Mifepristone—Nausea—Methotrexate—multiple sclerosis	4.84e-05	0.000588	CcSEcCtD
Mifepristone—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	4.83e-05	0.00176	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.81e-05	0.00175	CbGpPWpGaD
Mifepristone—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	4.74e-05	0.00172	CbGpPWpGaD
Mifepristone—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	4.74e-05	0.00172	CbGpPWpGaD
Mifepristone—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	4.67e-05	0.0017	CbGpPWpGaD
Mifepristone—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	4.67e-05	0.0017	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—CD86—multiple sclerosis	4.65e-05	0.00169	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—ZFP36L1—multiple sclerosis	4.63e-05	0.00168	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—MMP9—multiple sclerosis	4.62e-05	0.00168	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—IL10—multiple sclerosis	4.56e-05	0.00166	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	4.56e-05	0.00166	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—multiple sclerosis	4.52e-05	0.00165	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—multiple sclerosis	4.48e-05	0.00163	CbGpPWpGaD
Mifepristone—AR—Androgen receptor signaling pathway—STAT3—multiple sclerosis	4.47e-05	0.00163	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—PTBP1—multiple sclerosis	4.47e-05	0.00162	CbGpPWpGaD
Mifepristone—AR—Gene Expression—HNRNPA1—multiple sclerosis	4.46e-05	0.00162	CbGpPWpGaD
Mifepristone—AR—Gene Expression—U2AF2—multiple sclerosis	4.46e-05	0.00162	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—IL4—multiple sclerosis	4.43e-05	0.00161	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—LINGO1—multiple sclerosis	4.39e-05	0.0016	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	4.34e-05	0.00158	CbGpPWpGaD
Mifepristone—CYP3A5—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.31e-05	0.00157	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—IL2—multiple sclerosis	4.3e-05	0.00157	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—FAS—multiple sclerosis	4.09e-05	0.00149	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	4.06e-05	0.00148	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—PGR—multiple sclerosis	4.03e-05	0.00147	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	4.02e-05	0.00146	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—SRM—multiple sclerosis	3.92e-05	0.00143	CbGpPWpGaD
Mifepristone—NR3C1—Endoderm Differentiation—TGFB1—multiple sclerosis	3.9e-05	0.00142	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—MYC—multiple sclerosis	3.82e-05	0.00139	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—TGFB1—multiple sclerosis	3.81e-05	0.00139	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TAGAP—multiple sclerosis	3.81e-05	0.00138	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.8e-05	0.00138	CbGpPWpGaD
Mifepristone—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.78e-05	0.00138	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—VDR—multiple sclerosis	3.7e-05	0.00135	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	3.67e-05	0.00133	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—PABPC1—multiple sclerosis	3.59e-05	0.00131	CbGpPWpGaD
Mifepristone—AR—Gene Expression—ZFP36L1—multiple sclerosis	3.53e-05	0.00128	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—MAPK1—multiple sclerosis	3.48e-05	0.00126	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—SRM—multiple sclerosis	3.42e-05	0.00124	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	3.4e-05	0.00124	CbGpPWpGaD
Mifepristone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—multiple sclerosis	3.4e-05	0.00124	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—CD80—multiple sclerosis	3.39e-05	0.00123	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—HNRNPA1—multiple sclerosis	3.38e-05	0.00123	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—U2AF2—multiple sclerosis	3.38e-05	0.00123	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.36e-05	0.00122	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—S1PR1—multiple sclerosis	3.33e-05	0.00121	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—multiple sclerosis	3.29e-05	0.0012	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—RPL5—multiple sclerosis	3.24e-05	0.00118	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—GPC5—multiple sclerosis	3.24e-05	0.00118	CbGpPWpGaD
Mifepristone—CYP3A7—Biological oxidations—POMC—multiple sclerosis	3.17e-05	0.00115	CbGpPWpGaD
Mifepristone—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.07e-05	0.00112	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—PGR—multiple sclerosis	3.06e-05	0.00111	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	3.02e-05	0.0011	CbGpPWpGaD
Mifepristone—ABCC1—Disease—GPC5—multiple sclerosis	3.02e-05	0.0011	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	2.94e-05	0.00107	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—IL6—multiple sclerosis	2.87e-05	0.00104	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—RGS1—multiple sclerosis	2.83e-05	0.00103	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—VDR—multiple sclerosis	2.82e-05	0.00102	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CYP27B1—multiple sclerosis	2.76e-05	0.001	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CYP24A1—multiple sclerosis	2.76e-05	0.001	CbGpPWpGaD
Mifepristone—AR—Gene Expression—PABPC1—multiple sclerosis	2.73e-05	0.000994	CbGpPWpGaD
Mifepristone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	2.73e-05	0.000993	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	2.72e-05	0.00099	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.7e-05	0.000982	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—GPR65—multiple sclerosis	2.68e-05	0.000976	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	2.68e-05	0.000975	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—ZFP36L1—multiple sclerosis	2.68e-05	0.000973	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—IL6—multiple sclerosis	2.67e-05	0.000971	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	2.66e-05	0.000968	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	2.58e-05	0.000939	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—IL6—multiple sclerosis	2.53e-05	0.00092	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—GPC5—multiple sclerosis	2.53e-05	0.000919	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—STAT3—multiple sclerosis	2.5e-05	0.000911	CbGpPWpGaD
Mifepristone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	2.47e-05	0.0009	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—SRM—multiple sclerosis	2.47e-05	0.000899	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—TNF—multiple sclerosis	2.47e-05	0.000898	CbGpPWpGaD
Mifepristone—AR—Gene Expression—RPL5—multiple sclerosis	2.47e-05	0.000897	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CXCL13—multiple sclerosis	2.45e-05	0.000892	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CCR1—multiple sclerosis	2.45e-05	0.000892	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CYP27B1—multiple sclerosis	2.41e-05	0.000876	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CYP24A1—multiple sclerosis	2.41e-05	0.000876	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	2.39e-05	0.00087	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—IL2—multiple sclerosis	2.38e-05	0.000866	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	2.36e-05	0.000857	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—TGFB1—multiple sclerosis	2.32e-05	0.000844	CbGpPWpGaD
Mifepristone—CYP3A5—Biological oxidations—POMC—multiple sclerosis	2.29e-05	0.000833	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.29e-05	0.000832	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	2.26e-05	0.00082	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	2.25e-05	0.000818	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	2.21e-05	0.000802	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—GPC5—multiple sclerosis	2.2e-05	0.000802	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—TNF—multiple sclerosis	2.17e-05	0.000788	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—VDR—multiple sclerosis	2.14e-05	0.000778	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.1e-05	0.000764	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—RRM1—multiple sclerosis	2.09e-05	0.000761	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—PABPC1—multiple sclerosis	2.07e-05	0.000754	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	2.02e-05	0.000733	CbGpPWpGaD
Mifepristone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.01e-05	0.000729	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—IL6—multiple sclerosis	1.99e-05	0.000725	CbGpPWpGaD
Mifepristone—ABCC1—Disease—RPL5—multiple sclerosis	1.96e-05	0.000714	CbGpPWpGaD
Mifepristone—AR—Gene Expression—PGR—multiple sclerosis	1.94e-05	0.000706	CbGpPWpGaD
Mifepristone—ABCC1—Disease—SLC11A1—multiple sclerosis	1.88e-05	0.000683	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	1.87e-05	0.000681	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—RPL5—multiple sclerosis	1.87e-05	0.000681	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—SRM—multiple sclerosis	1.87e-05	0.000678	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	1.86e-05	0.000676	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—RRM1—multiple sclerosis	1.83e-05	0.000664	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.81e-05	0.000658	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—VDR—multiple sclerosis	1.78e-05	0.000648	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—SRM—multiple sclerosis	1.76e-05	0.000639	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—IL6—multiple sclerosis	1.75e-05	0.000636	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CCL3—multiple sclerosis	1.75e-05	0.000636	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	1.74e-05	0.000633	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	1.74e-05	0.000633	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—TNF—multiple sclerosis	1.74e-05	0.000631	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PTGER4—multiple sclerosis	1.68e-05	0.000612	CbGpPWpGaD
Mifepristone—CYP2D6—Biological oxidations—POMC—multiple sclerosis	1.63e-05	0.000593	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CXCR3—multiple sclerosis	1.63e-05	0.000591	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.62e-05	0.000591	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CD28—multiple sclerosis	1.61e-05	0.000585	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.6e-05	0.000581	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GPC5—multiple sclerosis	1.59e-05	0.000579	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CCR2—multiple sclerosis	1.58e-05	0.000575	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	1.51e-05	0.00055	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CD28—multiple sclerosis	1.5e-05	0.000546	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—PGR—multiple sclerosis	1.47e-05	0.000536	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—MYC—multiple sclerosis	1.47e-05	0.000535	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CNR1—multiple sclerosis	1.46e-05	0.000531	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.4e-05	0.000508	CbGpPWpGaD
Mifepristone—AR—Gene Expression—VDR—multiple sclerosis	1.36e-05	0.000493	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—RRM1—multiple sclerosis	1.32e-05	0.00048	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYP27B1—multiple sclerosis	1.31e-05	0.000478	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYP24A1—multiple sclerosis	1.31e-05	0.000478	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CXCL10—multiple sclerosis	1.31e-05	0.000478	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.27e-05	0.000463	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	1.24e-05	0.00045	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	1.24e-05	0.00045	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.21e-05	0.00044	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—BCHE—multiple sclerosis	1.2e-05	0.000437	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GPC5—multiple sclerosis	1.2e-05	0.000437	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—SRM—multiple sclerosis	1.15e-05	0.000418	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CD86—multiple sclerosis	1.15e-05	0.000418	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GPC5—multiple sclerosis	1.13e-05	0.000412	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CCL5—multiple sclerosis	1.13e-05	0.000411	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—MYC—multiple sclerosis	1.12e-05	0.000407	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CD86—multiple sclerosis	1.07e-05	0.000389	CbGpPWpGaD
Mifepristone—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.07e-05	0.000387	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—BCHE—multiple sclerosis	1.05e-05	0.000381	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—SPP1—multiple sclerosis	1.05e-05	0.000381	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—VDR—multiple sclerosis	1.03e-05	0.000374	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CCR5—multiple sclerosis	1.02e-05	0.00037	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IL2RA—multiple sclerosis	1e-05	0.000365	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—RRM1—multiple sclerosis	9.96e-06	0.000362	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CCR5—multiple sclerosis	9.5e-06	0.000345	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—RRM1—multiple sclerosis	9.39e-06	0.000341	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—APOE—multiple sclerosis	9.27e-06	0.000337	CbGpPWpGaD
Mifepristone—ABCC1—Disease—HLA-A—multiple sclerosis	9.25e-06	0.000337	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	9.19e-06	0.000334	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	9.17e-06	0.000333	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	8.99e-06	0.000327	CbGpPWpGaD
Mifepristone—ABCC1—Disease—APOE—multiple sclerosis	8.64e-06	0.000314	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	8.56e-06	0.000311	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—MYC—multiple sclerosis	8.5e-06	0.000309	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CD80—multiple sclerosis	8.38e-06	0.000305	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	8.1e-06	0.000295	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	8.1e-06	0.000295	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—POMC—multiple sclerosis	7.96e-06	0.00029	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CD80—multiple sclerosis	7.81e-06	0.000284	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CCL2—multiple sclerosis	7.79e-06	0.000283	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—BCHE—multiple sclerosis	7.58e-06	0.000276	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GPC5—multiple sclerosis	7.41e-06	0.000269	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—APOE—multiple sclerosis	7.24e-06	0.000263	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—MYC—multiple sclerosis	7.08e-06	0.000257	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TYK2—multiple sclerosis	7.07e-06	0.000257	CbGpPWpGaD
Mifepristone—ABCC1—Disease—TYK2—multiple sclerosis	6.59e-06	0.00024	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—APOE—multiple sclerosis	6.31e-06	0.000229	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—POMC—multiple sclerosis	6.22e-06	0.000226	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—RRM1—multiple sclerosis	6.14e-06	0.000223	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CD4—multiple sclerosis	5.96e-06	0.000217	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IL2—multiple sclerosis	5.89e-06	0.000214	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.76e-06	0.000209	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—BCHE—multiple sclerosis	5.72e-06	0.000208	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—ALB—multiple sclerosis	5.67e-06	0.000206	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MMP9—multiple sclerosis	5.57e-06	0.000203	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—POMC—multiple sclerosis	5.42e-06	0.000197	CbGpPWpGaD
Mifepristone—AR—Gene Expression—MYC—multiple sclerosis	5.39e-06	0.000196	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—BCHE—multiple sclerosis	5.39e-06	0.000196	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—STAT3—multiple sclerosis	4.95e-06	0.00018	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—ALB—multiple sclerosis	4.94e-06	0.00018	CbGpPWpGaD
Mifepristone—ABCC1—Disease—STAT3—multiple sclerosis	4.62e-06	0.000168	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MYC—multiple sclerosis	4.6e-06	0.000167	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TGFB1—multiple sclerosis	4.59e-06	0.000167	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—APOE—multiple sclerosis	4.56e-06	0.000166	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MAPK1—multiple sclerosis	4.5e-06	0.000164	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MYC—multiple sclerosis	4.29e-06	0.000156	CbGpPWpGaD
Mifepristone—ABCC1—Disease—TGFB1—multiple sclerosis	4.28e-06	0.000156	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MAPK1—multiple sclerosis	4.2e-06	0.000153	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—MYC—multiple sclerosis	4.09e-06	0.000149	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—POMC—multiple sclerosis	3.92e-06	0.000143	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ALB—multiple sclerosis	3.57e-06	0.00013	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—BCHE—multiple sclerosis	3.53e-06	0.000128	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IL6—multiple sclerosis	3.46e-06	0.000126	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—APOE—multiple sclerosis	3.44e-06	0.000125	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—APOE—multiple sclerosis	3.24e-06	0.000118	CbGpPWpGaD
Mifepristone—ABCC1—Disease—IL6—multiple sclerosis	3.23e-06	0.000117	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—POMC—multiple sclerosis	2.96e-06	0.000108	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—POMC—multiple sclerosis	2.79e-06	0.000101	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ALB—multiple sclerosis	2.7e-06	9.8e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ALB—multiple sclerosis	2.54e-06	9.24e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—APOE—multiple sclerosis	2.12e-06	7.71e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—POMC—multiple sclerosis	1.82e-06	6.62e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ALB—multiple sclerosis	1.66e-06	6.04e-05	CbGpPWpGaD
